Pre-incubation with CD8 antibody suppressed the cytolytic activity of spleen cells from 2 mAb-treated mice (Figure 5D) and we conclude that combined mAb treatment elicited a tumor antigen-specific CTL response mediated by CD8+ T cells. This evidence concerns the gene CD8A and neoplasm.